Sledovať
Konstantinos Kostikas
Konstantinos Kostikas
Respiratory Medicine Department University of Ioannina Medical School
Overená e-mailová adresa na: uoi.gr
Názov
Citované v
Citované v
Rok
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ...
European Respiratory Journal 49 (4), 2017
5892017
pH in expired breath condensate of patients with inflammatory airway diseases
K Kostikas, G Papatheodorou, K Ganas, K Psathakis, P Panagou, ...
American journal of respiratory and critical care medicine 165 (10), 1364-1370, 2002
5832002
Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function
AD Flouris, MS Chorti, KP Poulianiti, AZ Jamurtas, K Kostikas, ...
Inhalation toxicology 25 (2), 91-101, 2013
5462013
Oxidative stress in expired breath condensate of patients with COPD
K Kostikas, G Papatheodorou, K Psathakis, P Panagou, S Loukides
Chest 124 (4), 1373-1380, 2003
2832003
At the root: defining and halting progression of early chronic obstructive pulmonary disease
FJ Martinez, MLK Han, JP Allinson, RG Barr, RC Boucher, PMA Calverley, ...
American journal of respiratory and critical care medicine 197 (12), 1540-1551, 2018
2682018
Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy …
KR Chapman, JR Hurst, SM Frent, M Larbig, R Fogel, T Guerin, D Banerji, ...
American journal of respiratory and critical care medicine 198 (3), 329-339, 2018
2622018
Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits
M Vasilopoulou, AI Papaioannou, G Kaltsakas, Z Louvaris, N Chynkiamis, ...
European Respiratory Journal 49 (5), 2017
2492017
Toward clinically applicable biomarkers for asthma: an EAACI position paper
Z Diamant, S Vijverberg, K Alving, A Bakirtas, L Bjermer, A Custovic, ...
Allergy 74 (10), 1835-1851, 2019
2052019
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
GJ Rodrigo, D Price, A Anzueto, D Singh, P Altman, G Bader, F Patalano, ...
International journal of chronic obstructive pulmonary disease, 907-922, 2017
1752017
Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma
K Kostikas, M Gaga, G Papatheodorou, T Karamanis, D Orphanidou, ...
Chest 127 (5), 1553-1559, 2005
1712005
Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
AI Papaioannou, K Kostikas, P Kollia, KI Gourgoulianis
Respiratory research 7, 1-13, 2006
1682006
Artificial intelligence/machine learning in respiratory medicine and potential role in asthma and COPD diagnosis
A Kaplan, H Cao, JM FitzGerald, N Iannotti, E Yang, JWH Kocks, ...
The Journal of Allergy and Clinical Immunology: In Practice 9 (6), 2255-2261, 2021
1632021
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers
G Krommidas, K Kostikas, G Papatheodorou, A Koutsokera, ...
Respiratory medicine 104 (1), 40-46, 2010
1452010
Serum uric acid as a predictor of mortality and future exacerbations of COPD
K Bartziokas, AI Papaioannou, S Loukides, A Papadopoulos, A Haniotou, ...
European respiratory journal 43 (1), 43-53, 2013
1442013
VEGF, TNF-α and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer
E Dalaveris, T Kerenidi, A Katsabeki-Katsafli, T Kiropoulos, K Tanou, ...
Lung cancer 64 (2), 219-225, 2009
1382009
Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications
S Oikonomidi, K Kostikas, I Tsilioni, K Tanou, KI Gourgoulianis, ...
Current medicinal chemistry 16 (10), 1214-1228, 2009
1322009
Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis
ZD Daniil, E Papageorgiou, A Koutsokera, K Kostikas, T Kiropoulos, ...
Pulmonary pharmacology & therapeutics 21 (1), 26-31, 2008
1302008
Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies
J Bousquet, M Humbert, PG Gibson, K Kostikas, X Jaumont, P Pfister, ...
The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2702-2714, 2021
1282021
Defining a severe asthma super-responder: findings from a Delphi process
JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ...
The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021
1272021
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
AI Papaioannou, K Bartziokas, S Tsikrika, F Karakontaki, E Kastanakis, ...
European Respiratory Journal 41 (4), 815-823, 2013
1142013
Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.
Články 1–20